Hospital
Woodford Hospital LLC
Woodford Hospital LLC was paid $11.73M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 18% of everything it billed.
33Billing provider infoWOODFORD HOSPITAL LLC
VERSAILLES, KY 40383
VERSAILLES, KY 40383
33aNPI1588745012assigned 10/18/2006
33bProvider typeCritical Access Hospital
28Total paid$11.73M
24GClaims154,386
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Kentucky
Rank by total paid#9 of 16
Median peer was paid$11.73M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,408 | $1.68M | |
| 2019 | 21,086 | $1.51M | |
| 2020 | 18,248 | $1.42M | |
| 2021 | 21,184 | $1.59M | |
| 2022 | 24,921 | $1.83M | |
| 2023 | 26,153 | $1.97M | |
| 2024incomplete | 20,386 | $1.73M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 18% | 2,114 | 1,800 | $2.17M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 8,384 | 7,187 | $1.87M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 13,213 | 11,472 | $1.81M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.5% | 2,513 | 1,921 | $992K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.6% | 9,072 | 2,412 | $536K |
| 80053 | Comprehensive metabolic panel | 3.0% | 10,685 | 6,897 | $358K |
| 71046 | Radiologic examination, chest; 2 views | 3.0% | 3,970 | 3,244 | $356K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.4% | 3,266 | 2,977 | $280K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.2% | 704 | 487 | $262K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 4,427 | 3,552 | $223K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 3,076 | 2,582 | $209K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 3,089 | 2,515 | $162K |
73 more codes
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.2% | 4,001 | $145K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 8,711 | $144K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.2% | 1,120 | $135K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 3,577 | $132K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 10,850 | $128K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 1,618 | $121K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,820 | $104K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,257 | $97K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,568 | $94K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,843 | $93K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,345 | $91K |
| 81001 | <1% | 6,521 | $90K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 389 | $85K |
| 84484 | <1% | 2,445 | $61K | |
| 81025 | <1% | 2,766 | $61K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,301 | $57K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 100 | $56K |
| 97162 | <1% | 800 | $54K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 850 | $54K |
| 83690 | <1% | 2,382 | $49K | |
| 73630 | <1% | 485 | $48K | |
| 87070 | <1% | 2,377 | $44K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,299 | $43K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,027 | $36K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,540 | $34K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,264 | $34K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,843 | $34K |
| 73562 | <1% | 344 | $33K | |
| 73130 | <1% | 303 | $31K | |
| 73610 | <1% | 293 | $30K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,636 | $29K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,346 | $24K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,738 | $22K |
| 73030 | <1% | 208 | $22K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 14 | $19K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 343 | $18K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,612 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 391 | $11K |
| 82962 | <1% | 470 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 462 | $9K |
| 83605 | <1% | 387 | $8K | |
| 97164 | <1% | 193 | $8K | |
| 87186 | <1% | 258 | $7K | |
| 83735 | <1% | 501 | $7K | |
| 87077 | <1% | 432 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 250 | $7K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $6K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 605 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 249 | $5K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 318 | $5K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 144 | $4K |
| 83880 | <1% | 95 | $4K | |
| 87807 | <1% | 150 | $3K | |
| 86140 | <1% | 236 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 34 | $3K |
| 72100 | <1% | 29 | $3K | |
| 71271 | <1% | 62 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 140 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 246 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 12 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 264 | $2K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 483 | $1K |
| 85610 | <1% | 142 | $1K | |
| 85379 | <1% | 44 | $1K | |
| 73110 | <1% | 14 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 35 | $745.50 |
| 97035 | <1% | 24 | $664.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 80 | $525.85 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 103 | $429.48 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 28 | $294.44 |
| 85027 | <1% | 12 | $283.64 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 14 | $202.23 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 17 | $171.43 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.